Other Preterm Infants
12
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
88.9%
+2.4% vs benchmark
8%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Cognitive Processing in Preterm Infants and NICU Music Therapy
Impact of Preterm Body Composition at Discharge on 2 Years Neurological Development (ASQ Evaluation)
Surfactant Positive Airway Pressure and Pulse Oximetry Trial
The Effect of Vitamin D Administration to Premature Infants on Vitamin D Status and Respiratory Morbidity
Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation
Monitoring of Vital Signs During Skin-to-skin Holding by Mothers of Their Preterm Babies
Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants
Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure
Invictus Medical, Medical Cranial Support Device (CSD) is a Device Safety Study in Infants at Risk of Head Ulcers.
Probiotic Supplementation to Improve the GUT Microbiota of Very Low Birth Weight Preterm, a Pilot Study
Swallowing Sound in Preterm Infant Evaluation of Feeding Maturation
Clinical Tolerance of Numeta 13%